Isradipine
- Product NDC
- 50268-455
- 11-digit product format
- 502680455
- Labeler code
- 50268
- Product ID
- 50268-455_e87e2c26-cd7c-ee2a-e053-2995a90aaef9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Isradipine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA077317
- Marketing category
- ANDA
- Marketing start
- 2014-01-06
- Marketing end
- 2022-10-31
- Substance
- ISRADIPINE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-455-15 | 50268045515 | 50 BLISTER PACK in 1 BOX (50268-455-15) > 1 CAPSULE in 1 BLISTER PACK (50268-455-11) | 50 blister pack | 2014-01-06 | 0000-00-00 | No | No | Current |